España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
MarketBeat
Benzinga Contributor
About
MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, fina...
Show More
IBM Up 10 Days in a Row: What's Driving the Winning Streak?
Markets have staged a fierce rally in the last month, led by typical tech giants like NVIDIA, Meta Platforms, Microsoft, and… wait, is that IBM’s music? Yes, International Business Machines Corp. (NYSE:IBM)
Upstart Stock's Bull Case Just Got a Lot Stronger
The stock market has probably shaken out some investors with its recent swings in the S&P 500 index. This new volatility period has been born of President Trump's implemented trade tariffs on most of the United
Higher Gulf Oil Output Puts These Energy Names in Play
There comes a time in the economic cycle when investors need to dig deeper into fundamentals and stay true to the market’s nature of reflecting tomorrow’s expectations in today’s prices; some
UnitedHealth Stock Dips: Is This a Value Buy Opportunity?
([content-module:CompanyOverview, NYSE:UNH) UnitedHealth Group (NYSE:UNH) is a dominant force within the healthcare sector, a critical industry that should be included in a diversified long-term investment portfolio.
Analysts Love Lovesac, But Investors Should Be Cautious
([content-module:CompanyOverview, NASDAQ:LOVE) Lovesac Company (NASDAQ:LOVE) is emerging from legal issues involving former executives and is on track for its share price to stage a rebound. The rebound will be
Intel's Price Spikes: Noise, or the First Notes of a Turnaround?
([content-module:CompanyOverview, NASDAQ:INTC) Intel Corporation (NASDAQ:INTC) has given investors a front-row seat to a market in conflict. The stock demonstrated significant volatility during the second week of June,
SoFi Stock's Next Test: Can It Justify Its Premium Valuation?
Since its launch into the public markets in 2020, SoFi Technologies Inc. (NASDAQ:SOFI) has had to overcome a variety of investor objections. However, before 2023, a premium valuation wasn’t one of them. The
Super Micro Computer Stock: 2 Levels Smart Money Is Watching
([content-module:CompanyOverview, NASDAQ:SMCI) Studying the chart to look at levels of entry and exit is not enough in today’s market; investors need to understand the story behind each candlestick, each day, and
Fastenal Stock After Split: Poised for 5 More Years of Gains
([content-module:CompanyOverview, NASDAQ:FAST) The hum of industrial operations and the rhythm of construction would not be possible without the stable supply chains that ensure the productivity of each
Gold and Commodities: Is the Bull Case Gaining Momentum?
The S&P 500 is finally approaching new all-time highs after a turbulent spring, driven by strong earnings and easing trade war tensions. And it’s not just domestic stocks rebounding; European markets are
Ignore the Noise—Samsara Stock Is Still a Strong Buy
([content-module:CompanyOverview, NYSE:IOT) Samsara Inc. (NYSE:IOT) is no stranger to being misunderstood by the market. Back in March, we highlighted how the stock's dip was actually a solid buying opportunity, and it
3 Stocks Set to Double—And There's Still Time to Buy
Chasing momentum trends is risky business for investors. By the time many retail investors are aware of building momentum for a particular stock, it may be too late to fully capitalize on future gains. Worse yet,
Analysts Can't Get Enough of These Little-Known Biopharma Stocks
The biopharmaceuticals industry is both exciting and risky for investors. Many leading growth stocks in the U.S. market are found in this sector, due to the significant rallies that biopharmaceutical
IonQ's $1B Acquisition and Drug Discovery Leap With NVIDIA
([content-module:CompanyOverview, NYSE:IONQ) IonQ (NYSE:IONQ) has been making waves among quantum computing stocks. Its bold statements and recent acquisitions have caught a lot of attention. On June 9, IonQ put out two
Betting on Disruption: Is Lemonade the Future of Insurance?
([content-module:CompanyOverview, NYSE:LMND) After a long period of intense volatility, Lemonade, Inc. (NYSE:LMND) is back in the spotlight. The insurance technology company's stock has delivered powerful returns
Oracle's Cloud Boom Is Just Getting Started
([content-module:CompanyOverview, NYSE:ORCL) Oracle (NYSE:ORCL) has been speaking to the markets for the last two years, and it is time to start listening. The rise of AI has altered its trajectory so significantly that
Netflix Sets New Highs—Price Targets Keep Climbing
([content-module:CompanyOverview, NASDAQ:NFLX) Netflix Inc. (NASDAQ:NFLX) is once again back in record territory, and it doesn’t look like it plans on slowing down anytime soon. The streaming giant has now fully
Starbucks Stock: Culture Fix May Be Key to Long-Term Growth
([content-module:CompanyOverview, NASDAQ:SBUX) Starbucks Corp. (NASDAQ:SBUX) is at the beginning of a high-stakes turnaround under new chief executive officer (CEO) Brian Niccol. However, while SBUX stock is up 11%
Alibaba's Dip Is a Gift—Here's the Price That Matters
Any investor who has been exposed to Chinese stocks has likely noticed a decline in sleep quality over the past few months. These names have become so volatile lately because of the same driving factor across the S&P
3 Summer Stocks With Insider Buying and Analyst Support
Summer is traditionally a time when lower volume can limit upward momentum. Nonetheless, it’s only a few weeks away from the next earnings season, and earnings drive stock price growth. Therefore, if investors